PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaCommercial · Prior Auth · Medical Policy · Hematology, Nephrology, Oncology +5 moreMedium impact

Intravenous Iron Therapy (CPB 0575, reviewed 2026-07-01)

Effective date
Not stated in the notice
Identified
Aug 16, 2026

Summary

Feraheme, Ferrlecit, Injectafer, Monoferric and Venofer are medically necessary only for commercial members who have a contraindication, intolerance or ineffective response to the lower cost alternatives generic ferumoxytol, generic iron sucrose, generic sodium ferric gluconate and INFeD (iron dextran) for the labeled indication. Precertification is required for Feraheme, Ferrlecit, generic sodium ferric gluconate, Injectafer, Monoferric, Venofer and generic iron sucrose in applicable plan designs. Intravenous iron is considered experimental, investigational or unproven for other indications, including acute mountain sickness and anemia of inflammation, and it is contraindicated for genetic hemochromatosis or hemochromatosis secondary to iron overload.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 8 steps
01Precertification: Precertification is required of Aetna participating providers for Feraheme, Ferrlecit, generic sodium ferric gluconate, Injectafer, Monoferric, Venofer and generic iron sucrose in applicable plan designs.
02Call (866) 752-7021 or fax (888) 267-3277 for precertification, and use the Statement of Medical Necessity forms listed under Specialty Pharmacy Precertification.
03Brand products: For Feraheme, Ferrlecit, Injectafer, Monoferric and Venofer, document a contraindication, intolerance or ineffective response to the equivalent generic alternative for the labeled indication (generic ferumoxytol, generic iron sucrose, generic sodium ferric gluconate or INFeD).
04If the less cost intravenous iron product does not have the labeled indication, the claim needs another intravenous iron product that has the required labeled indication.
05Iron deficiency anemia: Document iron deficiency anemia with an unsatisfactory response, intolerance or contraindication to oral iron administration, and confirm it with the policy thresholds, such as serum ferritin less than 30 ng/mL or transferrin saturation less than 20 percent without chronic kidney disease.
06Codes: Injectafer is billed under HCPCS J1439, Monoferric under J1437, Feraheme or generic ferumoxytol under Q0138 (non-ESRD use) or Q0139 (ESRD on dialysis), INFeD under J1750, Venofer under J1756 and Ferrlecit or generic sodium ferric gluconate under J2916, when selection criteria are met.
07Experimental indications: Aetna considers intravenous iron experimental, investigational or unproven for indications not listed as medically necessary in the policy, including acute mountain sickness and anemia of inflammation.
08Continuation of therapy: Continuation of therapy is medically necessary for members who meet criteria for an indication listed in the policy.

Codes mentioned

J1439J1437Q0138Q0139J1750J1756J2916J0885J0887J0888Q4081D50.0D50.9D62D63.0D63.1D63.8D64.81E83.10E83.110E83.111G25.81K50.00K51.00K91.1N18.6N18.9N92.2N92.4N95.0O99.011O99.019S72.001AT70.29XAZ52.010Z88.8Z90.3Z98.84Z99.2

Original notice

Intravenous Iron Therapy (CPB 0575, reviewed 2026-07-01)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account